To include your compound in the COVID-19 Resource Center, submit it here.

FDA approves Breo Ellipta for adults, not children

FDA approved an sNDA on Thursday for Breo Ellipta fluticasone furoate/vilanterol from GlaxoSmithKline plc (LSE:GSK;

Read the full 153 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE